Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VictORION-INCLUSION: Evaluating INClisiran as a soLUtion to Improve LDL-C Management and cloSe Care Gaps in an Inclusive ASCVD and ASCVD Risk Equivalent populatiON

NCT06249165 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT06249165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06249165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VictORION-INCLUSION: Evaluating INClisiran as a soLUtion to Improve LDL-C Management and cloSe Care Gaps in an Inclusive ASCVD and ASCVD Risk Equivalent populatiON
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
December 16, 2024
Completion date
February 28, 2027
Enrollment
130 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease